Naïve Bayesian Models for Vero Cell Cytotoxicity
- 29 June 2018
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 35 (9) , 1-10
Abstract
Purpose To advance translational research of potential therapeutic small molecules against infectious microbes, the compounds must display a relative lack of mammalian cell cytotoxicity. Vero cell cytotoxicity (CC50) is a common initial assay for this metric. We explored the development of naïve Bayesian models that can enhance the probability of identifying non-cytotoxic compounds. Methods Vero cell cytotoxicity assays were identified in PubChem, reformatted, and curated to create a training set with 8741 unique small molecules. These data were used to develop Bayesian classifiers, which were assessed with internal cross-validation, external tests with a set of 193 compounds from our laboratory, and independent validation with an additional diverse set of 1609 unique compounds from PubChem. Results Evaluation with independent, external test and validation sets indicated that cytotoxicity Bayesian models constructed with the ECFP_6 descriptor were more accurate than those that used FCFP_6 fingerprints. The best cytotoxicity Bayesian model displayed predictive power in external evaluations, according to conventional and chance-corrected statistics, as well as enrichment factors. Conclusions The results from external tests demonstrate that our novel cytotoxicity Bayesian model displays sufficient predictive power to help guide translational research. To assist the chemical tool and drug discovery communities, our curated training set is being distributed as part of the Supplementary Material. Naive Bayesian models have been trained with publically available data and offer a useful tool for chemical biology and drug discovery to select for small molecules with a high probability of exhibiting acceptably low Vero cell cytotoxicity.Keywords
Funding Information
- National Institutes of Health (U19AI109713)
This publication has 41 references indexed in Scilit:
- Understanding Cytotoxicity and Cytostaticity in a High-Throughput Screening CollectionACS Chemical Biology, 2016
- Structural findings of phenylindoles as cytotoxic antimitotic agents in human breast cancer cell lines through multiple validated QSAR studiesToxicology in Vitro, 2015
- Oversampling to Overcome Overfitting: Exploring the Relationship between Data Set Composition, Molecular Descriptors, and Predictive Modeling MethodsJournal of Chemical Information and Modeling, 2013
- Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosisTuberculosis, 2012
- PubChem's BioAssay DatabaseNucleic Acids Research, 2011
- Predicting cytotoxicity from heterogeneous data sources with Bayesian learningJournal of Cheminformatics, 2010
- A Predictive Ligand-Based Bayesian Model for Human Drug-Induced Liver InjuryDrug Metabolism and Disposition, 2010
- The Trouble with QSAR (or How I Learned To Stop Worrying and Embrace Fallacy)Journal of Chemical Information and Modeling, 2007
- QSAR treatment of multiple toxicities: the mutagenicity and cytotoxicity of quinolinesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- An Information-Intensive Approach to the Molecular Pharmacology of CancerScience, 1997